Frailty as a marker of adverse outcomes in patients with bladder cancer undergoing radical cystectomy

被引:90
|
作者
Chappidi, Meera R. [1 ]
Kates, Max [1 ]
Patel, Hiten D. [1 ]
Tosoian, Jeffrey J. [1 ]
Kaye, Deborah R. [1 ]
Sopko, Nikolai A. [1 ]
Lascano, Danny [2 ]
Liu, Jen-Jane [1 ]
McKiernan, James [2 ]
Bivalacqua, Trinity J. [1 ]
机构
[1] Johns Hopkins Med Inst, James Buchanan Brady Urol Inst, Baltimore, MD 21205 USA
[2] Columbia Univ Coll Phys & Surg, Herbert Irving Canc Ctr, Dept Urol, 630 W 168th St, New York, NY 10032 USA
关键词
Bladder cancer; Frailty; Radical cystectomy; Perioperative outcomes; PERIOPERATIVE COMPLICATIONS; MORTALITY; GENDER; PERFORMANCE; MORBIDITY; RATES; RISK;
D O I
10.1016/j.urolonc.2015.12.010
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: To investigate the modified frailty index (mFI) as a preoperative predictor of postoperative complications following radical cystectomy (RC) in patients with bladder cancer. Materials and methods: Patients undergoing RC were identified from the National Surgical Quality Improvement Program participant use files (2011-2013). The mFI was defined in prior studies with 11 variables based on mapping the Canadian Study of Health and Aging Frailty Index to the National Surgical Quality Improvement Program comorbidities and activities of daily livings. The mFI groups were determined by the number of risk factors per patient (0, 1, 2, and >= 3). Univariable and multivariable regression were performed to determine predictors of Clavien 4 and 5 complications, and a sensitivity analysis was performed to determine the mFI value that would be a significant predictor of Clavien 4 and 5 complications. Results: Of the 2,679 cystectomy patients identified, 843 (31%) of patients had an mFI of 0, 1176 (44%) had an mFI of 1, 555 (21%) had an mFI of 2, and 105 (4%) had an mFI >= 3. Overall, 1585 (59%) of patients experienced a Clavien complication. When stratified at a cutoff of mFI >= 2, the overall complication rate was not different (61.7% vs. 58.3%, P = 0.1), but the mFI2 or greater group had a significantly higher rate of Clavien grade 4 or 5 complications (14.6% vs. 8.3%, P < 0.001) and overall mortality rate (3.5% vs. 1.8%, P = 0.01) in the 30-day postoperative period. The multivariate logistic regression model showed independent predictors of Clavien grade 4 or 5 complications were age > 80 years (odds ratio [OR] = 1.58 [1.11-2.27]), mFI2 (OR = 1.84 [1.28-2.64]), and mFI3 (OR = 2.58 [1.47-4.55]). Conclusions: Among patients undergoing RC, the mFI can identify those patients at greatest risk for severe complications and mortality. Given that bladder cancer is increasing in prevalence particularly among the elderly, preoperative risk stratification is crucial to inform decision-making about surgical candidacy. (c) 2016 Elsevier Inc. All rights reserved.
引用
收藏
页码:256.e1 / 256.e6
页数:6
相关论文
共 50 条
  • [1] Frailty as a marker of adverse outcomes during cystectomy for urothelial cancer
    Kates, Max
    Patel, Hiten
    Sopko, Nikolai
    Liu, Jeri-Jane
    Pierorazio, Phillip M.
    Bivalacqua, Trinity
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [2] Optimizing surgical outcomes in bladder cancer patients undergoing radical cystectomy
    Pere, Maria
    Amantakul, Akara
    Sriplakich, Supon
    Tarin, Tatum
    FRONTIERS IN SURGERY, 2023, 9
  • [3] OUTCOMES IN PATIENTS UNDERGOING RADICAL CYSTECTOMY FOR RECURRENT BLADDER
    Wopat, Ross A.
    Skinner, Eila C.
    Mitra, Anirban P.
    Cai, Jie
    Miranda, Gus
    Daneshmand, Siamak
    JOURNAL OF UROLOGY, 2012, 187 (04): : E707 - E707
  • [4] Stage III substaging and outcomes in patients with bladder cancer undergoing radical cystectomy
    Hara, Shuhei
    Fukuokaya, Wataru
    Miki, Jun
    Taoka, Rikiya
    Saito, Ryoichi
    Matsui, Yoshiyuki
    Hatakeyama, Shingo
    Kawahara, Takashi
    Matsuda, Ayumu
    Kawai, Taketo
    Kato, Minoru
    Sazuka, Tomokazu
    Sano, Takeshi
    Urabe, Fumihiko
    Kashima, Soki
    Naito, Hirohito
    Murakami, Yoji
    Miyake, Makito
    Daizumoto, Kei
    Matsushita, Yuto
    Hayashi, Takuji
    Inokuchi, Junichi
    Sugino, Yusuke
    Shiga, Kenichiro
    Yamaguchi, Noriya
    Yamamoto, Shingo
    Yasue, Keiji
    Abe, Takashige
    Nakanishi, Shotaro
    Hashine, Katsuyoshi
    Fujii, Masato
    Nishihara, Kiyoaki
    Matsumoto, Hiroaki
    Tatarano, Shuichi
    Wada, Koichiro
    Sekito, Sho
    Maruyama, Ryo
    Nishiyama, Naotaka
    Nishiyama, Hiroyuki
    Kitamura, Hiroshi
    Kimura, Takahiro
    INTERNATIONAL JOURNAL OF UROLOGY, 2025,
  • [5] Outcomes After Urothelial Recurrence in Bladder Cancer Patients Undergoing Radical Cystectomy
    Mitra, Anirban P.
    Alemozaffar, Mehrdad
    Harris, Brianna N.
    Schuckman, Anne K.
    Skinner, Eila C.
    Daneshmand, Siamak
    UROLOGY, 2014, 84 (06) : 1420 - 1426
  • [6] Frailty and sarcopenia impact surgical and oncologic outcomes after radical cystectomy in patients with bladder cancer
    Pathak, Ram Anil
    Hemal, Ashok K.
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2018, 7 : S763 - S764
  • [7] THE MODIFIED FRAILTY INDEX AS A MARKER OF ADVERSE OUTCOMES DURING CYSTECTOMY FOR UROTHELIAL CANCER
    Kates, Max
    Patel, Hiten
    Joice, Gregory
    Tosoian, Jeffrey
    Sopko, Nikolai
    Liu, Jen-Jane
    Pierorazio, Phillip
    Bivalacqua, Trinity
    JOURNAL OF UROLOGY, 2015, 193 (04): : E854 - E854
  • [8] The role of lymphadenectomy in patients undergoing radical cystectomy for bladder cancer
    Stein J.P.
    Current Oncology Reports, 2007, 9 (3) : 213 - 221
  • [9] Outcome of patients undergoing radical cystectomy for invasive bladder cancer
    Gschwend, JE
    CONTROVERSIES IN URO-ONCOLOGY, 2002, 36 : 106 - 117
  • [10] MODIFIED IMMUNOSCORE IMPROVES PREDICTION OF SURVIVAL OUTCOMES IN PATIENTS UNDERGOING RADICAL CYSTECTOMY FOR BLADDER CANCER
    Bieri, Uwe
    Lorenz, Buser
    Wettstein, Marian S.
    Moch, Holger
    Saba, Karim A.
    Sulser, Tulio
    Hermanns, Thomas
    Poyet, Cedric
    JOURNAL OF UROLOGY, 2020, 203 : E842 - E842